STOCK TITAN
  1. Home
  2. Sec-filings
  3. CBIO
  4. [EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing

[EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 15, 2026 4:30 P.M.
Form: S-1
CIK: 0001253689
Company Name: CRESCENT BIOPHARMA, INC.
File Number: 333-292600

Source: View Original Filing on SEC EDGAR

Stock CBIO logo
Crescent Biopharma Inc

NASDAQ:CBIO

CBIO Rankings

#3769 Ranked by Market Cap
N/A Ranked by Dividends

CBIO Latest News

Jan 5, 2026
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
Dec 18, 2025
Crescent Biopharma Announces Grants of Inducement Awards
Dec 4, 2025
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
Dec 4, 2025
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
Nov 17, 2025
Crescent Biopharma Announces Grants of Inducement Awards

CBIO Latest SEC Filings

Jan 15, 2026
[424B3] CRESCENT BIOPHARMA, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 7, 2026
[S-1] CRESCENT BIOPHARMA, INC. Files IPO Registration Statement
Dec 17, 2025
[Form 4] CRESCENT BIOPHARMA, INC. Insider Trading Activity
Dec 17, 2025
[Form 4] CRESCENT BIOPHARMA, INC. Insider Trading Activity
Dec 17, 2025
[Form 4] CRESCENT BIOPHARMA, INC. Insider Trading Activity

CBIO Stock Data

380.58M
11.53M
6.62%
77.39%
0.93%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM